The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
The global Tizanidine market was valued at US$ 360 million in 2023 and is anticipated to reach US$ 530.7 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Tizanidine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tizanidine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tizanidine include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tizanidine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tizanidine.
Report Scope
The Tizanidine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tizanidine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tizanidine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Segment by Application
Kids
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tizanidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tizanidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
The global Tizanidine market was valued at US$ 360 million in 2023 and is anticipated to reach US$ 530.7 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Tizanidine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tizanidine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tizanidine include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tizanidine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tizanidine.
Report Scope
The Tizanidine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tizanidine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tizanidine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Segment by Application
Kids
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tizanidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tizanidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tizanidine Market Overview
1.1 Product Overview and Scope of Tizanidine
1.2 Tizanidine Segment by Type
1.2.1 Global Tizanidine Market Value Comparison by Type (2024-2030)
1.2.2 2mg Tablet
1.2.3 4mg Tablet
1.2.4 2mg Capsules
1.2.5 4mg Capsules
1.2.6 6mg Capsules
1.3 Tizanidine Segment by Application
1.3.1 Global Tizanidine Market Value by Application: (2024-2030)
1.3.2 Kids
1.3.3 Adults
1.4 Global Tizanidine Market Size Estimates and Forecasts
1.4.1 Global Tizanidine Revenue 2019-2030
1.4.2 Global Tizanidine Sales 2019-2030
1.4.3 Global Tizanidine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tizanidine Market Competition by Manufacturers
2.1 Global Tizanidine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tizanidine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tizanidine Average Price by Manufacturers (2019-2024)
2.4 Global Tizanidine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tizanidine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tizanidine, Product Type & Application
2.7 Tizanidine Market Competitive Situation and Trends
2.7.1 Tizanidine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tizanidine Players Market Share by Revenue
2.7.3 Global Tizanidine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tizanidine Retrospective Market Scenario by Region
3.1 Global Tizanidine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tizanidine Global Tizanidine Sales by Region: 2019-2030
3.2.1 Global Tizanidine Sales by Region: 2019-2024
3.2.2 Global Tizanidine Sales by Region: 2025-2030
3.3 Global Tizanidine Global Tizanidine Revenue by Region: 2019-2030
3.3.1 Global Tizanidine Revenue by Region: 2019-2024
3.3.2 Global Tizanidine Revenue by Region: 2025-2030
3.4 North America Tizanidine Market Facts & Figures by Country
3.4.1 North America Tizanidine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tizanidine Sales by Country (2019-2030)
3.4.3 North America Tizanidine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tizanidine Market Facts & Figures by Country
3.5.1 Europe Tizanidine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tizanidine Sales by Country (2019-2030)
3.5.3 Europe Tizanidine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tizanidine Market Facts & Figures by Country
3.6.1 Asia Pacific Tizanidine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tizanidine Sales by Country (2019-2030)
3.6.3 Asia Pacific Tizanidine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tizanidine Market Facts & Figures by Country
3.7.1 Latin America Tizanidine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tizanidine Sales by Country (2019-2030)
3.7.3 Latin America Tizanidine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tizanidine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tizanidine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tizanidine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tizanidine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tizanidine Sales by Type (2019-2030)
4.1.1 Global Tizanidine Sales by Type (2019-2024)
4.1.2 Global Tizanidine Sales by Type (2025-2030)
4.1.3 Global Tizanidine Sales Market Share by Type (2019-2030)
4.2 Global Tizanidine Revenue by Type (2019-2030)
4.2.1 Global Tizanidine Revenue by Type (2019-2024)
4.2.2 Global Tizanidine Revenue by Type (2025-2030)
4.2.3 Global Tizanidine Revenue Market Share by Type (2019-2030)
4.3 Global Tizanidine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tizanidine Sales by Application (2019-2030)
5.1.1 Global Tizanidine Sales by Application (2019-2024)
5.1.2 Global Tizanidine Sales by Application (2025-2030)
5.1.3 Global Tizanidine Sales Market Share by Application (2019-2030)
5.2 Global Tizanidine Revenue by Application (2019-2030)
5.2.1 Global Tizanidine Revenue by Application (2019-2024)
5.2.2 Global Tizanidine Revenue by Application (2025-2030)
5.2.3 Global Tizanidine Revenue Market Share by Application (2019-2030)
5.3 Global Tizanidine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Actavis Tizanidine Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Tizanidine Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Tizanidine Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Acorda
6.4.1 Acorda Corporation Information
6.4.2 Acorda Description and Business Overview
6.4.3 Acorda Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Acorda Tizanidine Product Portfolio
6.4.5 Acorda Recent Developments/Updates
6.5 Unichem Laboratories
6.5.1 Unichem Laboratories Corporation Information
6.5.2 Unichem Laboratories Description and Business Overview
6.5.3 Unichem Laboratories Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Unichem Laboratories Tizanidine Product Portfolio
6.5.5 Unichem Laboratories Recent Developments/Updates
6.6 APOTEX
6.6.1 APOTEX Corporation Information
6.6.2 APOTEX Description and Business Overview
6.6.3 APOTEX Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 APOTEX Tizanidine Product Portfolio
6.6.5 APOTEX Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Tizanidine Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 CorePharma
6.8.1 CorePharma Corporation Information
6.8.2 CorePharma Description and Business Overview
6.8.3 CorePharma Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CorePharma Tizanidine Product Portfolio
6.8.5 CorePharma Recent Developments/Updates
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Corporation Information
6.9.2 Dr. Reddy's Laboratories Description and Business Overview
6.9.3 Dr. Reddy's Laboratories Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddy's Laboratories Tizanidine Product Portfolio
6.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mylan Tizanidine Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Oxford PharmaGenesis
6.11.1 Oxford PharmaGenesis Corporation Information
6.11.2 Oxford PharmaGenesis Tizanidine Description and Business Overview
6.11.3 Oxford PharmaGenesis Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Oxford PharmaGenesis Tizanidine Product Portfolio
6.11.5 Oxford PharmaGenesis Recent Developments/Updates
6.12 Niche Generics Limited
6.12.1 Niche Generics Limited Corporation Information
6.12.2 Niche Generics Limited Tizanidine Description and Business Overview
6.12.3 Niche Generics Limited Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Niche Generics Limited Tizanidine Product Portfolio
6.12.5 Niche Generics Limited Recent Developments/Updates
6.13 CREDIT PHARMA
6.13.1 CREDIT PHARMA Corporation Information
6.13.2 CREDIT PHARMA Tizanidine Description and Business Overview
6.13.3 CREDIT PHARMA Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CREDIT PHARMA Tizanidine Product Portfolio
6.13.5 CREDIT PHARMA Recent Developments/Updates
6.14 YABANG
6.14.1 YABANG Corporation Information
6.14.2 YABANG Tizanidine Description and Business Overview
6.14.3 YABANG Tizanidine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 YABANG Tizanidine Product Portfolio
6.14.5 YABANG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tizanidine Industry Chain Analysis
7.2 Tizanidine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tizanidine Production Mode & Process
7.4 Tizanidine Sales and Marketing
7.4.1 Tizanidine Sales Channels
7.4.2 Tizanidine Distributors
7.5 Tizanidine Customers
8 Tizanidine Market Dynamics
8.1 Tizanidine Industry Trends
8.2 Tizanidine Market Drivers
8.3 Tizanidine Market Challenges
8.4 Tizanidine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
